Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine

Area of Science:

• Neuroscience
• Pharmacology
• Neurochemistry

Background:

• Amphetamine in the lateral hypothalamus causes anorexia and hypodipsia.
• These effects are linked to catecholaminergic pathways, involving dopamine and norepinephrine release and reuptake inhibition.
• Direct evidence for amphetamine-induced neurochemical release in this region was previously lacking.

Purpose of the Study:

• To provide direct evidence of amphetamine-induced neurochemical release in the lateral hypothalamus.
• To investigate the role of dopamine, norepinephrine, and serotonin in amphetamine's anorectic and hypodipsic effects.
• To measure extracellular monoamine levels and their metabolites using microdialysis.

Main Methods:

• Microdialysis was employed to measure extracellular monoamines and their metabolites in the lateral hypothalamus.
• Amphetamine was infused to assess its effects on neurotransmitter levels.
• Levels of serotonin, dopamine, norepinephrine, DOPAC, 5-HIAA, and HVA were quantified.

Main Results:

• Amphetamine infusion significantly increased extracellular serotonin, dopamine, and norepinephrine.
• A significant decrease in dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA) was observed.
• Homovanillic acid (HVA) levels remained unchanged, suggesting blocked reuptake and reduced neurotransmitter breakdown.

Conclusions:

• Amphetamine administration in the lateral hypothalamus leads to the release of dopamine, norepinephrine, and serotonin.
• The findings support the hypothesis that amphetamine's behavioral effects are mediated by these neurotransmitters.
• Blocked reuptake and subsequent reduction in metabolite levels indicate a net increase in synaptic neurotransmitter availability.